22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
In May 2020, the US Securities and Exchange Commission announced amendments to the rule and forms re...
Read More >
Textile Manufacturer Discriminated Against Experienced Sales Leader By Firing Him After Learning His...
Read More >
A recent Pennsylvania case examined whether an unsuccessful offeror on a county project has standing...
Read More >
On Wednesday, the House of Representatives passed the Farm Workforce Modernization Act, easing immig...
Read More >
In this episode of Trekking Through Compliance, we consider the episode The Doomsday Machine which a...
Read More >
SUPREME COURT HEARS DACA ARGUMENTS - On November 12, 2019, the U.S. Supreme Court heard almost 90 m...
Read More >